ONYA Therapeutics

ONYA Therapeutics is a biotechnology company developing novel pharmaceutical treatments for acute and chronic wounds.

The company's pipeline centres on a patented controlled-release drug delivery technology designed to manage wound exudate and reduce reliance on antibiotics, addressing antimicrobial resistance in wound care settings.

Lead assets are progressing through pre-clinical and early clinical development, targeting chronic wounds including diabetic foot ulcers.

ONYA serves healthcare providers and clinical partners seeking alternatives to antibiotic-dependent wound management.